Global viscosupplementation market is anticipated to increase to over $2.64 billion by 2021
PARSIPPANY, N.J., June 28, 2017 – Fidia Farmaceutici S.p.A., a world leader in the research, development and manufacturing of hyaluronan (HA)-based products, and its wholly owned subsidiary, FIDIA PHARMA USA Inc., are projecting continued growth in 2017. The global viscosupplementation market is anticipated

Our Four Leading Principles:

Innovation

Quality

Internationalization

Competitiveness

PARSIPPANY, NJ, May 8, 2017 – Fidia Farmaceutici S.p.A., a world leader in the research, development and manufacturing of hyaluronan (HA) – based products and its wholly owned subsidiary, Fidia Pharma USA Inc., announces their presence at the American Medical Society for Sports Medicine (AMSSM) 2017 Annual Meeting with an educational symposium on Thursday, May […]

Our Four Leading Principles:

Innovation

Quality

Internationalization

Competitiveness

HYMOVIS® has exceptional lubricating properties in moving cartilage to a low-friction regime. The study provides a unifying framework to evaluate the potential clinical efficacy of injectable hyaluronic acid therapies. PARSIPPANY, NJ., March 22, 2017 – Fidia Farmaceutici S.p.A., a world leader in the research, development and manufacturing of hyaluronic acid (HA) – based products and […]

Our Four Leading Principles:

Innovation

Quality

Internationalization

Competitiveness